Ten‑Year Trial Finds Meniscus Surgery Worsens Knee Health

Context Partial meniscectomy – trimming frayed cartilage in the knee – has been a go‑to treatment for meniscal tears, injuries common in sports and aging joints. The meniscus, a C‑shaped shock absorber between thigh and shin bones, often shows tears on MRI even in asymptomatic people. Over the past two decades, clinicians have debated whether surgery improves outcomes or merely addresses incidental findings.

Key Facts The Finnish study enrolled 146 adults aged 35‑65 from five hospitals and randomly assigned them to either partial meniscectomy or a sham operation, where incisions were made but no tissue was removed. After ten years, patients who received the real surgery scored lower on validated knee‑function scales, reported more pain, and showed greater radiographic progression of osteoarthritis. They also faced a higher likelihood of needing additional knee surgery. The investigators describe the results as a medical reversal – a widely used therapy proving ineffective or harmful.

The trial’s findings align with recent practice shifts: the proportion of meniscus surgeries in the UK has fallen from roughly 75 % of eligible cases to about 25 % as guidelines extend the waiting period for conservative treatment from three to six months. Orthopaedic leaders note that surgery may still help a subset of patients who experience a mechanical “catching” sensation, but pain relief alone remains unpredictable.

What It Means For patients with meniscal tears, the evidence now suggests that immediate surgery is more likely to worsen long‑term knee health than to provide benefit. Non‑operative approaches—physiotherapy, activity modification and watchful waiting—should be the first line of treatment. Clinicians are urged to apply the “think before you strike” principle and reserve surgery for clearly defined mechanical problems rather than pain alone.

Health systems and guideline bodies may need to accelerate the phase‑out of routine partial meniscectomy, especially as independent organisations already recommend discontinuation. Ongoing monitoring of surgery rates and patient outcomes will reveal whether practice changes keep pace with the evidence.

What to watch next: Upcoming updates from the American Academy of Orthopaedic Surgeons and the British Association for Surgery of the Knee will indicate whether official recommendations will fully align with the trial’s conclusions.